Rating History for Viridian Therapeutic (VRDN) by UBS

More Stocks Rated by UBS | Latest Ratings for VRDN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
6/29/2026 Michael Yee Maintain Buy
(Buy)		 50.00
(50.00)		  
 		   Details